Fair Value Measurements

9 Months Ended

Sep. 30, 2018

Fair Value Measurements

In accordance with the provisions of ASC 820, the following tables provide the valuation hierarchy classification of assets and liabilities that are carried at fair value and measured on a recurring and nonrecurring basis in our Condensed Consolidated Balance Sheet as of September 30, 2018 and December 31, 2017:



September 30, 2018 (dollars in millions)	Total			Level 1		Level 2			Level 3
Recurring fair value measurements:
Available-for-sale securities	$	42		$	42	$	—		$	—
Derivative assets	150			—		150			—
Derivative liabilities	(118		)	—		(118		)	—



December 31, 2017 (dollars in millions)	Total			Level 1		Level 2			Level 3
Recurring fair value measurements:
Available-for-sale securities	$	64		$	64	$	—		$	—
Derivative assets	253			—		253			—
Derivative liabilities	(78		)	—		(78		)	—

Valuation Techniques. Our available-for-sale securities include equity investments that are traded in active markets, either domestically or internationally, and are measured at fair value using closing stock prices from active markets. Our derivative assets and liabilities include foreign exchange contracts that are measured at fair value using internal models based on observable market inputs such as forward rates, interest rates, our own credit risk and our counterparties' credit risks. As of September 30, 2018, there were no significant transfers in or out of Level 1 and Level 2.

As of September 30, 2018, there has not been any significant impact to the fair value of our derivative liabilities due to our own credit risk. Similarly, there has not been any significant adverse impact to our derivative assets based on our evaluation of our counterparties' credit risks.

The following table provides carrying amounts and fair values of financial instruments that are not carried at fair value in our Condensed Consolidated Balance Sheet at September 30, 2018 and December 31, 2017:



	September 30, 2018						December 31, 2017
(dollars in millions)	Carrying Amount			Fair Value			Carrying Amount			Fair Value
Long-term receivables	$	128		$	125		$	127		$	121
Customer financing notes receivable	458			433			609			596
Short-term borrowings	(1,576		)	(1,576		)	(392		)	(392		)
Long-term debt (excluding capitalized leases)	(38,344		)	(38,803		)	(27,067		)	(29,180		)
Long-term liabilities	(295		)	(263		)	(362		)	(330		)

The following table provides the valuation hierarchy classification of assets and liabilities that are not carried at fair value in our Condensed Consolidated Balance Sheet at September 30, 2018 and December 31, 2017:



	September 30, 2018
(dollars in millions)	Total			Level 1		Level 2			Level 3
Long-term receivables	$	125		$	—	$	125		$	—
Customer financing notes receivable	433			—		433			—
Short-term borrowings	(1,576		)	—		(1,380		)	(196		)
Long-term debt (excluding capitalized leases)	(38,803		)	—		(38,465		)	(338		)
Long-term liabilities	(263		)	—		(263		)	—



	December 31, 2017
(dollars in millions)	Total			Level 1		Level 2			Level 3
Long-term receivables	$	121		$	—	$	121		$	—
Customer financing notes receivable	596			—		596			—
Short-term borrowings	(392		)	—		(300		)	(92		)
Long-term debt (excluding capitalized leases)	(29,180		)	—		(28,970		)	(210		)
Long-term liabilities	(330		)	—		(330		)	—

We had commercial aerospace financing and other contractual commitments totaling approximately $15.1 billion and $15.3 billion as of September 30, 2018 and December 31, 2017, respectively, related to commercial aircraft and certain contractual rights to provide product on new aircraft platforms. Associated risks on these commitments from changes in interest rates are mitigated because interest rates are variable during the commitment term and are set at the date of funding based on current market conditions, the fair value of the underlying collateral and the credit worthiness of the customers. As a result, the fair value of these financings is expected to equal the amounts funded.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details